| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |